Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.

Future Med Chem

School of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, YuQuan Road, Beijing 100049, PR China.

Published: March 2020

AI Article Synopsis

Article Abstract

The p21-activated kinases (PAKs) are involved in many important biological activity regulations. FRAX019, FRAX414, FRAX597, FRAX1036 and G-5555 were identified as PAKs inhibitors. Their detailed inhibitory mechanisms deserve further investigation. Molecular dynamics simulations and further calculations for the PAK1/inhibitor and PAK4/inhibitor complexes indicate that their binding free energies are basically consistent with the trend of experimental activity data. The anchoring of residues Leu347 and Leu398 is the structural basis for designing Afraxis PAK inhibitors. This study discloses the inhibitory mechanisms of FRAX019, FRAX414, FRAX597, FRAX1036 and G-5555 toward PAK1 and PAK4 and some clues to enhance kinase activities and selectivities, which will provide valuable information to the development of more potent and selective PAK inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2019-0273DOI Listing

Publication Analysis

Top Keywords

pak inhibitors
12
afraxis pak
8
frax019 frax414
8
frax414 frax597
8
inhibitory mechanisms
8
computational insight
4
insight mechanisms
4
mechanisms action
4
action selectivity
4
selectivity afraxis
4

Similar Publications

The increasing global population and urbanization have led to significant challenges in waste management, particularly concerning vacuum blackwater (VBW), which is the wastewater generated from vacuum toilets. Traditional treatment methods, such as landfilling and composting, often fall short in terms of efficiency and sustainability. Anaerobic digestion (AD) has emerged as a promising alternative, offering benefits such as biogas production and digestate generation.

View Article and Find Full Text PDF

P21-activated kinase 4 (PAK4) plays a crucial role in the proliferation and metastasis of various cancers. However, developing selective PAK4 inhibitors remains challenging due to the high homology within the PAK family. Therefore, developing highly selective PAK4 inhibitors is critical to overcoming the limitations of existing inhibitors.

View Article and Find Full Text PDF

Introduction Depression is a prevalent and debilitating condition that often requires long-term medication management. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used but have limitations in efficacy and tolerability for some individuals. New antidepressant drugs targeting multiple pathways have shown potential in recent research.

View Article and Find Full Text PDF

Introduction: SPLASH (NCT04647526) is a multicenter phase III trial evaluating the efficacy and safety of [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer (mCRPC). This study leveraged a lead-in phase to assess tissue dosimetry and evaluate preliminary safety and efficacy, prior to expansion into a randomized phase. Here we report those results.

View Article and Find Full Text PDF

Shock is a state of inadequate perfusion that affects vital organs. Cardiogenic shock (CS) predisposes patients to various arrhythmias. The adverse effect depends on intervention and pharmacogenomics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!